Explore the latest insights, innovations, and clinical applications in In Vitro Diagnostics (IVD) from ReopenTest.

All Categories Industry Insights & Trends POCT Solutions & Applications Technology & Innovation Clinical Cases & Studies Quality Control & Regulation Company News & Events Ultimate Guides

Digital PCR: A New Era in Tumor Diagnosis and the Inspiration of QIAGEN

Explore how digital PCR is revolutionizing tumor diagnosis, from early screening to precision treatment. The collaboration between QIAGEN and GENCURIX reveals its enormous potential and application prospects, leading tumor diagnosis into a new era.

POCT: How CRP/PCT Testing Reshapes Primary Care Diagnosis and Economic Benefits?

Explore the application of POCT point-of-care testing technology in primary care, focusing on how CRP/PCT testing can improve diagnostic accuracy, optimize clinic operational efficiency, and achieve precise antibiotic management.

Trinity Biotech HIV Test Approved: New Opportunities for POCT Globalization

Trinity Biotech's rapid HIV test product has been approved for overseas production, revealing the globalization and localization trends of the IVD industry, emphasizing cost control and market expansion, and bringing new opportunities for POCT.

How POCT Helps Primary Care Clinics Transform from Cost Centers to Value Hubs?

Explore how point-of-care testing (POCT) empowers primary healthcare, improves diagnostic efficiency, optimizes operational processes, improves patient experience, and ultimately achieves economic benefits and clinic value growth, transforming clinics from cost centers to value hubs.

POCT CRP/PCT: The Secret Weapon for Win-Win Diagnostics and Revenue in Primary Care Clinics

Explore how POCT CRP/PCT testing transforms the primary care clinic diagnostic model, improves diagnostic efficiency and patient satisfaction, while increasing clinic revenue and helping primary healthcare development.

Proteomics: A Sea of Stars or a Thorny Path for IVD?

Explore the potential and challenges of proteomics in in vitro diagnostics (IVD). This article provides an in-depth analysis of its applications, market opportunities, and technological bottlenecks, and looks forward to future development trends, revealing the next growth point of the IVD industry.

A Boon for Primary Care: CRP/PCT POCT Aids in Both Diagnosis & Revenue Growth

Explore how CRP/PCT POCT optimizes primary care processes, guides antibiotic use, and improves diagnostic efficiency in primary care, while bringing economic benefits. Learn how POCT empowers primary care and improves patient outcomes.

POCT: A New Paradigm for Infection Management and Business Growth Potential in Primary Care Clinics

Explore how POCT (point-of-care testing) technology is revolutionizing infection management in primary care clinics, especially CRP/PCT rapid testing, improving diagnosis and treatment efficiency and accuracy, and bringing commercial value and growth potential.

The "Secret" Battlefield of the IVD Industry: The Strategic Breakthrough of Biological Raw Materials

In-depth analysis of the importance of biological raw materials in the IVD industry, interpretation of the strategic significance behind two key acquisitions, revealing how it has become the core driving force for enterprises to reduce costs, increase efficiency, and innovate technology, as well as future development trends.

Insights into 2024 Global IVD Investment: Five Major Mergers Reveal New Trends

An analysis of the five major mergers and acquisitions in the global in vitro diagnostics (IVD) field in 2024, insights into industry investment hotspots and future development trends, including POCT, precision diagnosis, molecular diagnosis, etc., to provide reference for investors.

POCT Empowers Primary Care Clinics: CRP/PCT Testing Reshapes Diagnostic Efficiency and Value

Explore how POCT point-of-care testing technology, through CRP/PCT testing, improves diagnostic efficiency, optimizes patient experience, and brings commercial value to primary care clinics. Understand the application status and market prospects of POCT in primary care.

How POCT is Becoming a New Focus of Precision Medicine M&A: Deep Logic and Business Insights

In-depth analysis of how POCT point-of-care testing technology is becoming a focus of mergers and acquisitions in the diagnostic field under the wave of precision medicine. Analyze the market potential, technical advantages, and impact on the future medical ecosystem of POCT, and reveal the commercial logic behind it.